Is INCY up or down today?
INCY is down 2.73% today, last at 126.38. This stock moved -2.73% versus the prior close.
INCY · Incyte
INCY (Incyte) is trading at 126.38, down 2.73% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 37 headlines skew mostly positive. Earnings and Macro/Market themes dominated coverage.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
INCY is down 2.73% today, last at 126.38. This stock moved -2.73% versus the prior close.
Over the past 7 days, 37 headlines skew mostly positive. Earnings and Macro/Market themes dominated coverage. Dominant story: Incyte's Solid Q2 Seen Funding Strategy Beyond Jakafi Patent Expiration, RBC Says (1 source, neutral) RSI is 68 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 41% of recent mentions lean bullish — mixed social mood.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 10,305 mentions over 30d
Incyte's Solid Q2 Seen Funding Strategy Beyond Jakafi Patent Expiration, RBC Says
INCY Maintained by Guggenheim -- Price Target Raised to $150 - GuruFocus
Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results - Benzinga
INCY Maintained by BMO Capital -- Price Target Raised to $130 - GuruFocus
Incyte Says Opzelura Cream Approved in EU to Treat Moderate Atopic Dermatitis